All the subjects were on the diet for a month
For many patients especially those without insurance these compounded versions of GLP-1 medications provided an accessible and affordable way to access treatment for weight loss and Type 2 diabetes
Given the wide use of these drugs, these adverse events, although rare, must be considered by patients thinking about using them for weight loss, Mohit Sodhi, MSc, a fourth-year medical student at the University of British Columbia, said in a related press release
Wegovy clinical trials found that hair loss occurred more frequently among patients who lost over 20 percent of their weight in about a year and a half on the medication
A 42-year-old woman developed an immediate reaction to intramuscular cyanocobalamin B12, despite positive intradermal testing
As GLP-1 medications transform the treatment of obesity and chronic diseases, the Trump Administration is working to help more Medicare beneficiaries gain access to affordable treatments